Another #nasal feature not discussed here is our finding that >70% of #COVID19 outpatients produced transient, virus-induced anti-IFNα autoantibodies in the nose, associated with BETTER outcomes www.science.org/doi/10.1126/.... Host's antiviral immunity rather than a breach of immune tolerance?
Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19
Nasal IgA1 autoantibodies against IFN-α are associated with better COVID-19 prognosis, including fewer symptoms and robust anti–SARS-CoV-2 immunity.
science.org
To get better protection against respiratory infections and transmission we need to achieve nasal immunity. A new @cp-immunity.bsky.social review www.cell.com/immunity/abs...